CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute

G. Zoppoli, S. Solier, W. C. Reinhold, H. Liu, J. W. Connelly, A. Monks, R. H. Shoemaker, O. D. Abaan, S. R. Davis, P. S. Meltzer, J. H. Doroshow, Y. Pommier

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute'. Together they form a unique fingerprint.

Medicine & Life Sciences